Virtual Reality and Computerized Cognitive Intervention for Mild Cognitive Impairment in Heart Failure
Heart Failure, Mild Cognitive Impairment
About this trial
This is an interventional supportive care trial for Heart Failure focused on measuring heart failure, mild cognitive impairment, older adults, cognitive intervention, cognitive training, attention restoration, virtual reality
Eligibility Criteria
We will use a two-step process to screen and enroll the patients. First, we will screen potentially eligible patients from the Indiana University Health systems using these eligibility criteria. Inclusion Criteria: ≥ 55 years; chronic HF Stage C validated from echocardiography or comparable measure; ability to communicate in English; a someone (e.g., family member, significant other, close friend) who agrees to serve as an informant and provide information of the patient's IADL; and capacity to consent according to the Indiana University Institutional Review Board policies, or lacks capacity to consent but has the ability to provide assent from someone who can serve as LAR. Exclusion Criteria: pre-HF (Stages A and B) or advanced HF (Stage D); vision or hearing problems that can interfere with cognitive testing; major neurological disorder (e.g., previously diagnosed dementia, Parkinson's disease, epilepsy, multiple sclerosis); major psychiatric disease (e.g., schizophrenia, bipolar disorder); life-threatening unstable illness other than HF (e.g., end-stage cancer); and users of regular computerized cognitive training or participants in cognitive training trials in the past year. Second, we will enroll patients only if they have MCI by: 1) having MoCA score 23 and lower; and 2) not meeting criteria for dementia.
Sites / Locations
- Indiana UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
No Intervention
Vita (virtual reality-based cognitive restoration intervention)
Com (computerized cognitive training intervention )
Vita+Com (Both Vita and Com intervention)
Usual care
Participants randomized to Vita will receive a virtual reality head-mount device (e.g., Oculus Quest) to view nature pictures for 10 minutes (1 set of 10 pictures)/day, 2-3 days/week for 8 weeks (a total of 20 sets for 200 minutes, approximately 3.3 hours) based on the provided activity schedule. Participants will receive weekly check-in calls from the intervention RA during the 8 weeks of intervention phase.
Participants randomized to Com will receive a tablet computer (e.g., iPad) to complete BrainHQ training for 1 hour (6 exercises)/day, 2-3 days/week for 8 weeks (total of 20 hours) based on the provided activity schedule. Participants will receive weekly check-in calls from the intervention RA during the 8 weeks of intervention phase.
Participants randomized to Vita+Com will receive both Vita and Com simultaneously. They will spend 10 minutes on Vita and then 1 hour on Com per day, 2-3 days/week for 8 weeks (a total of 23.3 hours). Participants will receive weekly check-in calls from the intervention RA during the 8 weeks of intervention phase.
Participants randomized to this control condition will continue to receive their usual care, but no interventions from the study team. We will monitor changes in their activities that may affect changes in cognitive function (e.g., starting book clubs) by weekly check-in calls during the 8 weeks of intervention phase.